Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Kivu Bioscience Inc.
BioNTech SE
Eli Lilly and Company
AVEO Pharmaceuticals, Inc.
USWM, LLC (dba US WorldMeds)
Conjupro Biotherapeutics, Inc.
Pfizer
Aulos Bioscience, Inc.
Hoffmann-La Roche
Erasca, Inc.
Eli Lilly and Company
GlaxoSmithKline
Regeneron Pharmaceuticals
PMV Pharmaceuticals, Inc
ViroMissile, Inc.
Pfizer
Pfizer
Tizona Therapeutics, Inc
Tasca Therapeutics
ALX Oncology Inc.
Clasp Therapeutics, Inc.
MacroGenics
Adaptimmune
Solve Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Pierre Fabre Medicament
OncoNano Medicine, Inc.
VM Oncology, LLC
Regeneron Pharmaceuticals
Takeda
AccSalus Biosciences, Inc.
Therorna
Merck Sharp & Dohme LLC
Tempus AI
Massive Bio, Inc.
Incyte Corporation
Sanofi
Sichuan Baili Pharmaceutical Co., Ltd.
BioAtla, Inc.
GI Innovation, Inc.
Nurix Therapeutics, Inc.
Memgen, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Incyte Corporation
Yuhan Corporation
Medicenna Therapeutics, Inc.